Medindia LOGIN REGISTER
Medindia

Side effect(s) of Brigatinib


Review the side-effects of Brigatinib as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

  Common:
Nausea, diarrhea , fatigue or tiredness, headache, cough


  Gastrointestinal:
Constipation , pain in the abdomen, vomiting, loss of appetite, raised levels of the pancreatic enzymes amylase and lipase

  Cardiovascular:
Decreased heartrate, prolonged activated partial thromboplastin time, high blood pressure

  Central nervous system:
Lack of sleep, peripheral neuropathy, headache

  Respiratory:
Difficulty in breathing, cough, interstitial lung disease/pneumonitis, pneumonia

  Musculoskeletal:
Muscle pain, back pain, joint pain, pain in the extremity

  Skin:
Exfoliative rashes, itching, pustular rashes, acneiform dermatitis

  Eyes:
Blurred vision, double vision, reduced visual acuity


  Others:
Anemia, lymphopenia, fever, urosepsis, increased level of liver enzymes, increase in creatinine phosphokinase, high blood glucose levels, fever, allergic reaction

Other Precautions :

• Women of child-bearing age should be advised to use non-hormonal birth control methods for at least 4 months and men are advised to use a condom for at least 3 months after the last dose of brigatinib. Brigatinib treatment may be associated with infertility.
• It is necessary to advise patients to report to their physician if they experience unusual muscle pain or muscle tenderness or weakness.

Drug Name : Brigatinib

Brigatinib generic Brigatinib is an anticancer drug which is prescribed to treat patients with anaplastic lymphoma kinase (ALK) positive metastatic non-small cell lung cancer (NSCLC) for patients who have progressed with or experience side effects with crizotinib , another drug used to treat the cancer.


Advertisement